Cargando…
A comparative analysis of deferoxamine treatment modalities for dermal radiation‐induced fibrosis
The iron chelator, deferoxamine (DFO), has been shown to potentially improve dermal radiation‐induced fibrosis (RIF) in mice through increased angiogenesis and reduced oxidative damage. This preclinical study evaluated the efficacy of two DFO administration modalities, transdermal delivery and direc...
Autores principales: | Lavin, Christopher V., Abbas, Darren B., Fahy, Evan J., Lee, Daniel K., Griffin, Michelle, Diaz Deleon, Nestor M., Mascharak, Shamik, Chen, Kellen, Momeni, Arash, Gurtner, Geoffrey C., Longaker, Michael T., Wan, Derrick C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572785/ https://www.ncbi.nlm.nih.gov/pubmed/34612609 http://dx.doi.org/10.1111/jcmm.16913 |
Ejemplares similares
-
Abstract 129: Transdermal Deferoxamine Mitigates Radiation-induced Skin Fibrosis
por: Borrelli, Mimi R., et al.
Publicado: (2020) -
Prophylactic treatment with transdermal deferoxamine mitigates radiation-induced skin fibrosis
por: Shen, Abra H., et al.
Publicado: (2020) -
Transdermal deferoxamine administration improves excisional wound healing in chronically irradiated murine skin
por: Lintel, Hendrik, et al.
Publicado: (2022) -
1: Fat Grafting Improves Dorsal Skin Fibrosis after Radiation in an Engrailed-1 Mouse Model
por: Abbas, Darren B., et al.
Publicado: (2021) -
Abstract 1: Transdermal Deferoxamine Alleviates Radiation-Induced Damage In Porcine Skin
por: Adem, Sandeep, et al.
Publicado: (2020)